Lab-Grown Mini-Tumors used to pick best cancer drugs
NCT ID NCT07405346
Summary
This study is testing a new, personalized way to choose the first treatment for advanced leiomyosarcoma, a type of cancer. Doctors will take a small sample of a patient's tumor and grow a miniature version of it in a lab. They will test different chemotherapy drugs on this 'organoid' to see which one works best before giving it to the patient. The goal is to see if this method leads to better treatment responses and helps patients live longer without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED LEIOMYOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430000, China
Conditions
Explore the condition pages connected to this study.